Author:
Onat Altan,Erginel-Unaltuna Nihan,Çoban Neslihan,Çiçek Gökhan,Yüksel Hüsniye
Subject
Clinical Biochemistry,General Medicine
Reference25 articles.
1. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in dyslipidaemic patients;Fruchart;Diab Vasc Dis Res,2008
2. Inhibition of lipoprotein lipase activity by synthetic peptides of apolipoprotein C-III;McConathy;J Lipid Res,1992
3. VLDL, apolipoproteins B, CIII, and E, and risk of recurrent coronary events in the Cholesterol and Recurrent Events (CARE) trial;Sacks;Circulation,2000
4. LDL containing apolipoprotein CIII is an independent risk factor for coronary events in diabetic patients;Lee;Arterioscler Thromb Vasc Biol,2003
5. Apolipoprotein C-III, metabolic syndrome and risk of coronary artery disease;Olivieri;J Lipid Res,2003
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献